Every year, millions of patients are diagnosed with pulmonary nodules, and as increasing numbers of people undergo lung cancer screening, even more patients will be found to have a nodule. The vast majority of patients cannot benefit from the detection of a pulmonary nodule because most are benign. Accordingly, it is important to develop strategies to minimize harm, in particular the distress of a "near-cancer" diagnosis. In other settings, communication strategies are critical mediators of patient-centered outcomes for those with cancer and those at-risk of cancer. We conducted multiple studies to characterize the experience of patients with the diagnosis and evaluation of incidental pulmonary nodules, measure patient-centered outcomes for patients with pulmonary nodules, and determine the association of patient-clinician communication practices with those outcomes. We learned that a substantial proportion of 
and evaluation of a pulmonary nodule. Accordingly, it is important to mitigate the severity and frequency of these harms. Harris et al 8 proposed a taxonomy of harms that result from a "near-cancer" diagnosis after a nodule is detected through lung cancer screening. This taxonomy applies equally to incidental nodule detection and includes physical harms, psychological harms, financial strain, and opportunity costs.
We believe it is critical to evaluate patient-centered outcomes following nodule detection for several reasons. First, incidental nodule detection is already common, and with the advent of screening, clinicians risk becoming inundated with patients with pulmonary nodules that require evaluation. Second, we wanted to evaluate patients with a low risk of lung cancer because this group represents the vast majority of those with a nodule. Many studies have focused on the impact of cancer detection on patients but fewer on the impact of a "near-cancer" diagnosis.
Third, almost everyone with a nodule has a risk of suffering psychological harm. When we started our research studies, however, there were no data on the likelihood or magnitude of those harms. As an example from a related setting, we knew that patients with falsepositive mammograms frequently experience distress. 9, 10 In the context of false-positive mammograms, distress is often short-lived and resolved when results of a breast biopsy are negative. However, most patients with pulmonary nodules undergo radiographic surveillance rather than biopsy, leaving them in a state of uncertainty for months or years about whether they have cancer. We each had clinical experiences talking with patients who experienced profound and prolonged distress after their pulmonary nodule was detected. Thus, we wanted to study how commonly distress occurred and how severe it was for patients with nodules. We focused on psychological harm because most patients with small nodules undergo radiologic surveillance and are less likely to suffer physical harm or financial strain. Furthermore, for the subset of patients who do undergo invasive procedures, physical harms may be hard to change, as they result from mostly fixed patient and imaging characteristics (eg, comorbid illness, size and location of nodule).
Finally, and most importantly, we wanted to understand if there were mechanisms to influence distress and other patient-centered outcomes. We hypothesized that communication strategies would be a likely, if not the only, mechanism to influence distress. We also reasoned that understanding this communication process would provide valuable insights into how clinicians made recommendations about nodule surveillance and what impact these processes had on patients' adherence to recommendations.
The Studies Begin
Simultaneously but independently, we applied for and were awarded career development awards from the National Cancer Institute (Dr Wiener) and the Department of Veterans Affairs (VA) (Dr Slatore). The proposed studies were a mix of qualitative and quantitative analyses of patients with nodules along with the clinicians who care for these patients. The main differences in the designs were that Dr Wiener included patients from several health-care systems in the northeastern United States and focused on large-scale cross-sectional analyses. Dr Slatore performed a smaller study but with longitudinal evaluations and only included patients from one VA facility in the northwestern United States. The goal of the studies was to evaluate the association of communication practices, as reported by both patients and clinicians, with patientcentered outcomes. The primary outcome was distress, but adherence, knowledge, and satisfaction were also studied. When available, validated instruments were used to measure these outcomes (Table 1) .
We were guided by theoretical models of patientcentered communication to help measure and analyze communication strategies. These models emphasize the separate practices that comprise communication, which can each be measured and replicated. Most models agree on four core domains (Fig 1): (1) information exchange, in which a clinician informs a patient about the risks and benefits of diagnostic and treatment options; (2) understanding the patient as a person and his or her preferences and values, which can be divided into tasks such as fostering healing relationships, responding to emotions, and managing uncertainty 11 ; (3) shared decision-making, which combines adequate information exchange with considering patients' values and preferences to make an informed decision that is shared between the patient and clinician; and (4) establishing a therapeutic alliance so that the patient and clinician are "on the same page." Some patient-centered communication models also emphasize the "clinician as person" domain, which incorporates the personal qualities of 
What We Found
Overall, most of our results from both cohorts studied were similar and complemented each other, with a few differences that are highlighted here.
As we suspected, many participants were distressed after they were diagnosed with an incidental nodule. Our qualitative studies showed that many seemed not at all or only mildly distressed, but some reported severe levels of distress, particularly in the period immediately following nodule detection. For example, one participant reported how she "bawled through Christmas" 17 while
another reported feeling like he had received a "death sentence" 18 after finding out about the nodule. Many of our participants reported that they immediately assumed they had cancer ( 21 Although the average levels of distress decreased over time, almost 60% reported having mild or greater levels of distress at least once during surveillance, and 25% still had at least mild distress after 2 years of nodule surveillance. 22 Notably, the average distress scores in both our studies were higher than those reported among lung cancer screening trial 23, 24 participants with nodules, although they followed the same trend of a short-term peak in distress that tended to decline over time. 25, 26 We also evaluated adherence to recommendations regarding nodule surveillance, including the separate contributions of patients and clinicians in the chain of adherence. We found in our longitudinal nodule study that patients and clinicians were each adherent approximately 75% of the time, and almost 40% of participants had at least one episode of nonadherence during surveillance, 27 echoing the results of other studies. [28] [29] [30] Importantly, clinician nonadherence was not associated with lung cancer risk factors, suggesting that when clinicians deviate from surveillance guidelines, they make this decision based on factors extrinsic to the patient's objective risk of lung cancer, a result found in other studies. 29, 31 However, despite reporting in qualitative studies that clinicians sometimes deviate from guidelines (eg, order an earlier scan) based on a patient's distress (Table 2) , 32, 33 there was no association between distress and clinician adherence. This finding suggests that clinicians underestimate distress or do not guide management decisions based on it. Furthermore, some clinicians believed there was an "optimal" level of distress that might motivate patients to be more adherent to recommended surveillance and that completely alleviating distress might have the chestjournal.org unintended consequence of reducing adherence. 32 In actuality, however, patients who were distressed were less adherent to surveillance, and there was no level of distress that was associated with improved adherence. This finding is similar to results in other cancer screening settings, 34 in which distress surrounding a false-positive result is negatively associated with adherence to subsequent screening. By contrast, highquality patient-clinician communication (as rated by patients) was associated with increased patient adherence to recommended nodule surveillance.
These results quantified the occurrence and magnitude of the problems, but we wanted to evaluate how communication strategies might mitigate them. In general, participants were satisfied with communication with their clinicians overall, and many reported it to be of high quality. However, we also found some systemic problems. Focusing first on the information exchange domain in our qualitative studies, we learned that participants had very little information about their nodules, a sentiment voiced by virtually every participant in our studies. Indeed, we titled our first papers, "What do you mean, a spot?" 17 and "What the heck is a nodule?" 18 because those were the exact words so many used when describing their experiences. The participants implicitly understood that the nodule was related to lung cancer, but very few had an accurate understanding of the level of risk, the plans for surveillance, or the rationale for active surveillance rather than biopsy (Table 2 ).
These findings were confirmed in our quantitative studies, 19, 21 in which most participants dramatically overestimated their risk of lung cancer. For example, in the longitudinal study, the mean AE SD lung cancer risk was 10% AE 12%, 20 whereas the average perceived risk was 39% AE 26%. Cancer risk was < 30% for 95% of participants, but only 30% perceived that the risk was < 30%. Participants also knew very little about the natural history of pulmonary nodules, 19 and their knowledge did not improve over the course of surveillance. 22, 35 The large majority of participants reported that they did not receive or could not remember receiving information about their risk of cancer. 19 Because patient self-report only reflects one-half of the communication dyad, we also interviewed primary care providers (PCPs) and pulmonologists to learn their approach to communication with patients with pulmonary nodules. PCPs confirmed that they seldom directly provided information about the risk of lung cancer (Table 2 ) and other details about surveillance to their patients. 32 They offered several explanations, including lack of time, lack of confidence in their own estimate of cancer risk, and the concern that providing too many details would be overwhelming and might actually increase patient distress. Pulmonologists, who mostly described seeing patients with larger nodules, more often provided risk information, although not universally. 33 Thus, we are confident that most patients with small nodules receive little information about their nodule, and the information they do receive is seldom tailored to their individual cancer risk.
Interestingly, and contrary to our hypotheses, selfperceived risk of lung cancer, as a measure of adequate information exchange, was not consistently associated with distress. Although distress was common, it was not nearly as frequent as patients' near universal lack of knowledge about cancer risk. Despite their limited knowledge of cancer risk, many patients were satisfied with the care and information they had received and did not seem distressed. This dichotomy seemed to be explained by the patients' trust in their clinicians, which was related to how clinicians communicated in the patient as person domain ( Table 2 ). As one participant said, "She's a good doctor, because she would call me back if it was serious. She wouldn't just let me go." 18 We also evaluated the association between information exchange and distress quantitatively. Perceived risk was not associated with distress in the large cross-sectional study or at baseline in the longitudinal study. However, perceived risk was modestly associated with distress in the longitudinal analyses, even though distress levels decreased during the period of active surveillance while perceived risk remained stable (a trend confirmed by the qualitative analyses). Overall, these findings suggest that strategies designed to improve knowledge about small nodules, with a goal to align the actual and perceived risk of lung cancer, may be insufficient to mitigate distress.
We next evaluated the association between the patient as person domain and distress. The qualitative studies suggested that patients experienced less distress when their clinicians were empathic and generated trust (Table 2) . 17, 18, 26 The quantitative studies strongly confirmed this finding. In the longitudinal study, we evaluated specific aspects of the patient as person domain and found that communication strategies which included partnership with the clinician, a personal relationship with the clinician, whether the clinician provided a positive and a clear approach to the problem, and whether the clinician was interested in the participant's life were all associated with decreased distress. 22 Turning to shared decision-making, we asked if participants wanted to make decisions by themselves about nodule surveillance, whether they wanted their clinician to decide for them, or whether they wanted to share the decision. In the quantitative studies, using the Control Preferences Scale (CPS), 36 participants almost always had a preferred role for the surveillance decision (56% shared, 24% clinician-controlled, and 20% patientcontrolled) but in almost 40% of encounters, they could not describe their actual role. 37 Although most patients wanted to participate in decision-making, 19 ,37 patients infrequently engaged in decision-making with clinicians, 38 often not recognizing that a decision had even been made. This finding was corroborated by clinicians who also reported that they seldom provided the level of information about the nodule that would be required to engage in true shared decision-making. In an international survey of clinicians who care for patients with pulmonary nodules, one-half reported that they are open to shared decision-making with patients about nodule evaluation. 39 In qualitative interviews, however, PCPs and many pulmonologists reported that they rarely engaged in shared decision-making with their patients about nodule evaluation (Table 2) . 32, 33 Based on these findings and the fact that information exchange about nodules was often inadequate, we suspect that true shared decision-making about nodule surveillance options seldom occurs, despite guidelines for pulmonary nodule evaluation explicitly recommending shared decision-making. 7 Among those participants able to rate their role in decision-making, a shared process was not associated with satisfaction with or perceived quality of medical care, lung cancer risk, reported quality of information received, or distress. 22, 37 However, role concordance in decision-making (ie, having the same preferred and actual decision-making roles) was associated with satisfaction with and perceived quality of medical care, although not with knowledge or distress. Similarly, the inability to report how the decision was made was not associated with distress (G. C. S., unpublished data).
Finally, the therapeutic alliance domain of communication was qualitatively evaluated. Not surprisingly, given the inadequate knowledge about nodules, patients often did not know the plan for surveillance (Table 2) . [17] [18] [19] 35 This lack of therapeutic alliance may explain some of the failure of distress to diminish over time among some patients. Most patients did not understand that surveillance is typically limited to 2 years (depending on nodule size) or that radiographic stability over that interval usually confirms that the nodule is benign. 17, 19, 26 Without that understanding, some patients experienced persistently elevated levels of distress throughout the period of radiographic surveillance and even after surveillance had ended. 22, 26 Meanwhile, the lack of therapeutic alliance and consequent poor understanding of the evaluation plan may also explain our finding that patients often were nonadherent to the surveillance plan. Without a robust nodule-tracking system in place, some patients would have failed to receive any surveillance at all. 27 Unfortunately, systems to prevent patients from "falling through the cracks" during nodule evaluation are not available in many health-care settings, 40 despite being recognized as a critical need by clinicians. 32 
Summary and Recommendations
These studies confirmed our hypotheses that for patients with incidentally detected nodules, distress is common, sometimes severe, and often long-lasting. A parallel finding is that nonadherence to recommended surveillance is frequent, with multiple causes. In general, patients were satisfied with the communication with their clinicians in the patient as person domain and often reported high levels of trust. However, there were clear deficiencies in patients' knowledge about nodules and a lack of shared decisionmaking. Despite these communication deficiencies, their impact on distress and adherence may be low. Indeed, it seems that communication strategies focusing on the patient as person domain are more likely to have an effect on patient-centered outcomes.
Clinicians were worried that too much distress was obviously detrimental to patients. They used multiple strategies to decrease distress but one that stood out was some clinicians' decision to avoid talking about cancer. Patients uniformly asked for more information about nodules, specifically about the risk of cancer, and those who did receive it more often found this information reassuring rather than anxiety-provoking. 19 Accordingly, the strategy of withholding cancer information to reduce distress is likely ineffectual. Clinicians also believed that no distress might be associated with worse adherence. Our results echo those from mammography, 34 which also found that distress is associated with worse adherence with no "optimal" level. Thus, we believe that the risk of unintended consequences from interventions designed to increase knowledge about the risk of lung cancer and/or decrease distress is low.
chestjournal.org Recognize that the nodule may be an important concern for patients and allow time for discussion of the patient's questions. Avoid minimizing or dismissive language
Information exchange

Patient-level suggestions
Provide information about the causes of nodules, rationale for active surveillance rather than immediate biopsy, and follow-up plan details, including benefits and harms
Report the semi-quantitative risk of lung cancer and relevant nodule information that relates to risk prediction (eg, lack of growth decreases malignancy risk)
Describe the follow-up plan in detail, including possible steps if the nodules change (eg, biopsy or surgery for growing nodule)
Use pictures, summary tables, and plain, simple language Ask what role the patient prefers in the decision-making process Example "When we make this decision about what to do about your nodule, some patients want to make the decision on their own, some just want me to decide, and many want something in the middle. How about you?"
If the patient is comfortable with a shared approach, actively engage patients in decisions regarding the follow-up evaluation
The link between actual risk of lung cancer, perceived risk, and distress is both interesting and complicated. We hypothesized that a large driver of distress for patients with nodules would be a misperception that the risk of lung cancer was much higher than the actual risk. Although we found that indeed this misperception was common, it does not seem to be strongly associated with distress.
Interventions that focus on information about nodules, one of the primary goals of decision aids, may be necessary to improve knowledge but are likely not sufficient to improve distress if used on their own without communication strategies that also include communication about individual patient's values and preferences.
Despite widespread recommendations for shared decision-making, we were not surprised that it rarely occurred, as in many other clinical contexts. 41 Even among participants who could rate how the nodule surveillance decision was made, shared decision-making and role concordance were not associated with distress. We measured shared decision-making with the CPS, a widely used but imperfect instrument. 42, 43 Our findings on the whole indicate that "true" shared decision-making, with adequate information exchange and consideration of patients' preferences and values, seldom occurred. The CPS does not capture these subtleties, and we therefore suggest not using the CPS as a single measure of successful shared decision-making. It may be adequate to use in preliminary studies of new communication interventions, such as decision aids, as a measure of communication processes but may not be appropriate as a measure of actual patient-centered outcomes.
Patient and Clinician Suggestions Table 3 includes several examples of suggestions that participants offered for how clinicians could improve communication. Overall, patients wanted more information about the relative size of the nodule, the associated risk of lung cancer, and the plan for follow-up (e-Appendix 1 includes a sample information letter). Additional strategies that patients found reassuring but were underutilized by clinicians included explaining that nodules were a common finding and highlighting the small size of the nodule on the CT image. 19 We also included several examples of how to improve communication in the patient as person domain. Changes in this domain may be challenging but likely essential for improving patient-centered outcomes. Meanwhile, clinicians expressed a need for better tools to share information with patients and systems-level methods to improve adherence to their recommended surveillance. To meet some of these needs, we developed a patient education document about pulmonary nodules. 44 
Limitations
As with all studies, the present studies have limitations. First, the longitudinal analyses and mixed-methods analyses improve the likelihood that the associations observed are causal, but observational studies can never truly assess causality. Thus, communication interventions should be empirically tested for their effect on patient-centered outcomes. Second, because two diverse cohorts were studied, the overall results may be more generalizable than the results would be if taken separately. However, there is still a need to study associations of communication with patient-centered outcomes in other settings, most notably among patients undergoing lung cancer screening. Third, our studies assessed communication as reported by patients and clinicians, which may differ from actual communication.
Only recorded or observed studies of clinic visits or telephone conversations can assess what really happened. 
Conclusions
Many patients are diagnosed with a pulmonary nodule, and it is common to be distressed, sometimes severely, as a result. Patients want more information and should be provided with it. It is unclear, however, if improved information exchange, by itself and without attention to individual patient values and preferences, will improve patient-centered outcomes. Similarly, shared decisionmaking is important, but additional or new measures are needed because current instruments are mostly associated with process measures that may be less relevant for patients. Furthermore, decision aids, which mainly focus on knowledge, may not suffice for improving other patient-centered outcomes such as distress. 45 Although we focused on patients with incidentally detected nodules, these results from routine clinical practice may be more generalizable to patients with screening-detected nodules in the real world than results from randomized trials. 46 If so, screening is likely to cause distress for many patients, and current recommendations to use decision aids may be insufficient to mitigate that distress. We are currently conducting a study to assess the impact of screening and quality of communication on patient-centered outcomes in the usual-care context. 47 Given the large number of patients who may undergo screening in the near future, it is important to continue to study and refine strategies to minimize its harm.
